The India neuropathic pain market is expanding as diabetes prevalence, neurological disorders, cancer treatment, ageing populations, and chronic pain awareness increase. The market was valued at USD 487.5 million in 2024 and is projected to reach USD 1.038 billion by 2035, growing at a CAGR of 7.11%. Neuropathic pain is associated with damage or dysfunction affecting the nervous system. It may...